ConductScience.org, home

Paper8348751

Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): the presence of normal level of clusterin and the possible implication in the atherosclerosis.

Choi-Miura NH and 7 others. Clin Exp Immunol, 1993. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): the presence of normal level of clusterin and the possible implication in the atherosclerosis. Papers, record 8348751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8348751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): the presence of normal level of clusterin and the possible implication in the atherosclerosis.
PubMed
Journal
Clin Exp Immunol
PubMed
Year
1993
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.43
iCite
Revised in PubMed
2019-05-12
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Choi-Miura NHN H
2Sakamoto TT
3Ohtaki SS
4Nakamura HH
5Ishizawa SS
6Takagi YY
7Gomi KK
8Tomita MM

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ArteriosclerosisMajor topic
Complement System ProteinsMajor topic
GlycoproteinsMajor topic
Lipoproteins, HDLMajor topic
Molecular ChaperonesMajor topic
Tangier DiseaseMajor topic
Adult
Clusterin
Complement Membrane Attack Complex
Female
Humans
Lipids

Source PubMed

Download CSV of topics

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17130397Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier).J Clin Invest1982https://conductscience.org/library/papers/7130397PubMed
26790903Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease).Metabolism1981https://conductscience.org/library/papers/6790903PubMed
36871313Ram rete testis fluid contains a protein (clusterin) which influences cell-cell interactions in vitro.Biol Reprod1983https://conductscience.org/library/papers/6871313PubMed
46554279The activation of human complement component C5 by a fluid phase C5 convertase.J Biol Chem1983https://conductscience.org/library/papers/6554279PubMed
56412234Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6412234PubMed
66311077Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis.Annu Rev Biochem1983https://conductscience.org/library/papers/6311077PubMed
76651915A Japanese family with high density lipoprotein deficiency.Atherosclerosis1983https://conductscience.org/library/papers/6651915PubMed
86725246Tangier disease. In vitro conversion of proapo-A-ITangier to mature APO-A-ITangier.J Biol Chem1984https://conductscience.org/library/papers/6725246PubMed
96432845Comparative in vitro study of the pro-apolipoprotein A-I to apolipoprotein A-I converting activity between normal and Tangier plasma.J Clin Invest1984https://conductscience.org/library/papers/6432845PubMed
103910058Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque.Atherosclerosis1985https://conductscience.org/library/papers/3910058PubMed
113511384The pathogenesis of atherosclerosis--an update.N Engl J Med1986https://conductscience.org/library/papers/3511384PubMed
123056433The complement system in atherosclerosis.Atherosclerosis1988https://conductscience.org/library/papers/3056433PubMed
132469247Immunohistochemical localization of S protein/vitronectin in human atherosclerotic versus arteriosclerotic arteries.Virchows Arch A Pathol Anat Histopathol1989https://conductscience.org/library/papers/2469247PubMed
142474572Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions.J Clin Invest1989https://conductscience.org/library/papers/2474572PubMed
152549301Endocytic pathway of high density lipoprotein via trans-Golgi system in rat resident peritoneal macrophages.Lab Invest1989https://conductscience.org/library/papers/2549301PubMed
162780565Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein 2, a constituent of rat testis fluid.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2780565PubMed
172477686Induction of the TRPM-2 gene in cells undergoing programmed death.Mol Cell Biol1989https://conductscience.org/library/papers/2477686PubMed
182601725A serum protein SP40,40 modulates the formation of membrane attack complex of complement on erythrocytes.Mol Immunol1989https://conductscience.org/library/papers/2601725PubMed
192299741Characterization of the products of a gene expressed during androgen-programmed cell death and their potential use as a marker of urogenital injury.J Urol1990https://conductscience.org/library/papers/2299741PubMed
202391426Sandwich ELISA assay for quantitative measurement of SP-40,40 in seminal plasma and serum.J Immunol Methods1990https://conductscience.org/library/papers/2391426PubMed

See all 40 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
28242049High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis.Atherosclerosis2017https://conductscience.org/library/papers/28242049PubMed
15014888[A 52-year old female patient with recurrent shock of unclear origin, hemoconcentration and hypoalbuminemia].Internist (Berl)2004https://conductscience.org/library/papers/15014888PubMed
8687416Apolipoprotein J and Alzheimer's amyloid beta solubility.Biochem J1996https://conductscience.org/library/papers/8687416PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APOA1335PubTator's text mininghttps://conductscience.org/library/genes/335NCBI Gene
APOA2336PubTator's text mininghttps://conductscience.org/library/genes/336NCBI Gene
CLU1191PubTator's text mininghttps://conductscience.org/library/genes/1191NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8348751

GET https://conductscience.org/api/papers/v1/8348751/references?page=2